FDA approves Glenmark’s generic azelaic acid gel


Glenmark Pharmaceuticals, which is based in India, has announced that the FDA has approved its ANDA to produce a generic version of Bayer Healthcare’s Finacea topical gel. The gel had annual sales of $128 million in the last year, according to IMS data.

Read the source article at financialexpress.com

About the Author

Related Posts

Leave a Reply